The Discounted Cash Flow (DCF) valuation of 10X Genomics Inc (TXG) is (89.55) USD. With the latest stock price at 14.21 USD, the upside of 10X Genomics Inc based on DCF is -730.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 7.4% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (198.40) - (58.37) | (89.55) |
| Upside | -1496.7% - -510.9% | -730.4% |